NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Platform Demonstrates Excellent Results in Delivery of APIs to the Brain

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative delivery platform, DehydraTECH, has demonstrated excellent results in delivery of nicotine to the brain in a recent lab study. An article discussing this reads, “The new report confirmed first generation results of in vivo tests on live animals showing that DehydraTECH was able to deliver more active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, as reported in an article published by the CFN Media Group (http://nnw.fm/oN1Xp). Because of certain similarities in physical structure between the nicotine molecule and several of the drugs used to treat diseases such as Huntington’s, Parkinson’s, schizophrenia and depression, it is now theorized that DehydraTECH could offer similar delivery advantages.”

To view the full article, visit http://nnw.fm/YioQ3

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. licenses disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com

More from NetworkNewsBreaks

NetworkNewsBreaks – The Flowr Corp. and The Needle Capital Corp. Successfully Complete Qualifying Transaction NetworkNewsBreaks – SinglePoint, Inc. (SING) President Announces Launch of SingleCoin App in Interview on MoneyTV NetworkNewsBreaks – BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF) to Present Clinical Trial Data at Two Upcoming NYC Conferences

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Recent News

What's next for Paul Allen's big investments? It's not clear

Oct 20, 2018

SEATTLE — Prior to his death on Monday, billionaire Microsoft co-founder Paul Allen invested large sums in technology ventures, research projects and philanthropy, some of it eclectic and highly speculative. What happens to those commitments now? Outside of bland assurances from his investment company, no one seems quite sure. Allen died in Seattle from complications of non-Hodgkin's lymphoma, according to his company Vulcan Inc. He was 65. He never married and had no children, and details of his estate aren't known. Forbes recently estimated Allen's net worth at $20.3 billion. He used much of the money he made from Microsoft...

Treasury employee charged in leak linked to Mueller's probe

Oct 20, 2018

WASHINGTON — A Treasury Department employee was accused Wednesday of leaking confidential banking reports of suspects charged in special counsel Robert Mueller's investigation, and an unidentified high-ranking colleague was cited in court papers as a co-conspirator but was not charged. Natalie Mayflower Sours Edwards, a senior official at the department's Financial Crimes Enforcement Network, also known as FinCEN, is accused of leaking several confidential suspicious activity reports to a journalist, whose name was not disclosed in court papers. But the documents list about a dozen stories published by BuzzFeed News over the past year and a half. A spokesman for...

Paul Allen's passions: Rock n' roll, sports and philanthropy

Oct 20, 2018

SEATTLE — Personal computers, conservation, pro football, rock n' roll and rocket ships: Paul G. Allen couldn't have asked for a better way to spend, invest and donate the billions he reaped from co-founding Microsoft with childhood friend Bill Gates. Allen used the fortune he made from Microsoft — whose Windows operating system is found on most of the world's desktop computers — to invest in other ambitions, from tackling climate change and advancing brain research to finding innovative solutions to solve some of the world's biggest challenges. "If it has the potential to do good, then we should do...

Paul Allen, Microsoft co-founder and philanthropist, dies

Oct 20, 2018

SEATTLE — Paul G. Allen, who co-founded Microsoft with his childhood friend Bill Gates before becoming a billionaire philanthropist, technology investor and owner of several professional sports teams, has died. He was 65. He died Monday in Seattle, according to his company Vulcan Inc. Earlier this month Allen announced that the non-Hodgkin's lymphoma that he was treated for in 2009 had returned and he planned to fight it aggressively. Gates said he was heartbroken about the loss of one of his "oldest and dearest friends." "Personal computing would not have existed without him," Gates said in a statement, adding that...

Microsoft co-founder, philanthropist Paul Allen dies at 65

Oct 20, 2018

SEATTLE — Paul G. Allen, who co-founded Microsoft with his childhood friend Bill Gates before becoming a billionaire philanthropist who invested in conservation, space travel, arts and culture and professional sports, died Monday. He was 65. He died in Seattle from complications of non-Hodgkin's lymphoma, his company Vulcan Inc. announced. Gates said he was heartbroken about the loss of one of his "oldest and dearest friends." "Personal computing would not have existed without him," Gates said in a statement. "But Paul wasn't content with starting one company. He channeled his intellect and compassion into a second act focused on improving...

About Us

Science Buzz is a user-friendly website which concentrates on news for the Big Three: Biology, Chemistry, and Physics.

Contact us: sales@thescnbuzz.com